$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000104733516000180 Filed on February 19, 2016

Income Statement

Concept	2015 Q4	2015	2014 Q4
Revenue	$233.9M	$906.6M	$226.4M
YoY Change	3.34%	4.01%	9.47%
Cost Of Revenue	$140.0M	$532.7M	$136.0M
YoY Change	2.94%	4.41%	10.21%
Gross Profit	$94.00M	$373.9M	$90.40M
YoY Change	3.98%	3.45%	8.39%
Gross Profit Margin	40.18%	41.24%	39.93%
Selling, General & Admin	$10.00M	$39.97M	$10.00M
YoY Change	0.0%	0.59%	2.04%
% of Gross Profit	10.64%	10.69%	11.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.700M	$37.11M	$9.300M
YoY Change	4.3%	7.94%	24.0%
% of Gross Profit	10.32%	9.93%	10.29%
Operating Expenses	$72.90M	$304.2M	$69.60M
YoY Change	4.74%	4.43%	9.61%
Operating Profit	$20.22M	$67.13M	$20.20M
YoY Change	0.09%	-1.3%	1.53%
Interest Expense	$4.400M	$2.608M	$3.800M
YoY Change	15.79%	20.46%	-32.14%
% of Operating Profit	21.76%	3.89%	18.81%
Other Income/Expense, Net	$5.246M		$4.392M
YoY Change	19.44%		-61811904885660160.0%
Pretax Income	$25.50M	$85.27M	$24.60M
YoY Change	3.66%	0.1%	-3.53%
Income Tax	$10.50M	$32.13M	$9.800M
% Of Pretax Income	41.18%	37.68%	39.84%
Net Earnings	$14.98M	$53.14M	$14.80M
YoY Change	1.19%	-0.42%	-10.84%
Net Earnings / Revenue	6.4%	5.86%	6.54%
Basic Earnings Per Share	$1.03	$3.34	$0.92
Diluted Earnings Per Share	$0.99	$3.20	$0.88
COMMON SHARES
Basic Shares Outstanding		13.89M
Diluted Shares Outstanding		14.49M

Balance Sheet

Concept	2015 Q4	2015	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$154.4M	$154.4M	$202.3M
YoY Change	-23.68%	-23.69%	8.36%
Cash & Equivalents	$38.21M	$38.21M	$69.77M
Short-Term Investments	$116.2M	$116.2M	$132.5M
Other Short-Term Assets	$29.30M	$29.24M	$29.10M
YoY Change	0.69%	0.53%	14.12%
Inventory	$7.568M	$7.568M	$7.127M
Prepaid Expenses
Receivables	$84.10M	$84.10M	$78.84M
Other Receivables	$3.700M	$3.663M	$5.200M
Total Short-Term Assets	$278.9M	$278.9M	$322.5M
YoY Change	-13.51%	-13.51%	7.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$536.0M	$536.0M	$514.7M
YoY Change	4.14%	4.14%	12.68%
Goodwill	$17.60M		$17.60M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments	$37.70M	$37.68M	$37.10M
YoY Change	1.62%	1.53%	-4.38%
Other Assets	$230.3M	$162.4M	$236.9M
YoY Change	-2.75%	-4.27%	51.25%
Total Long-Term Assets	$766.4M	$766.4M	$751.6M
YoY Change	1.97%	1.97%	9.77%
TOTAL ASSETS
Total Short-Term Assets	$278.9M	$278.9M	$322.5M
Total Long-Term Assets	$766.4M	$766.4M	$751.6M
Total Assets	$1.045B	$1.045B	$1.074B
YoY Change	-2.68%	-2.68%	9.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.10M	$20.13M	$15.90M
YoY Change	26.42%	26.77%	21.37%
Accrued Expenses	$92.40M	$92.41M	$86.70M
YoY Change	6.57%	6.6%	-1.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.300M	$3.279M	$3.100M
YoY Change	6.45%	6.19%
Total Short-Term Liabilities	$150.7M	$150.7M	$183.6M
YoY Change	-17.92%	-17.92%	9.39%
LONG-TERM LIABILITIES
Long-Term Debt	$120.0M	$150.2M	$10.00M
YoY Change	1100.0%	245.29%	0.0%
Other Long-Term Liabilities	$16.29M	$104.4M	$16.01M
YoY Change	1.77%	-7.58%	-86.49%
Total Long-Term Liabilities	$136.3M	$254.6M	$26.01M
YoY Change	423.99%	62.76%	-79.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$150.7M	$150.7M	$183.6M
Total Long-Term Liabilities	$136.3M	$254.6M	$26.01M
Total Liabilities	$287.0M	$414.3M	$209.6M
YoY Change	36.92%	21.87%	-29.25%
SHAREHOLDERS EQUITY
Retained Earnings	$368.0M		$343.9M
YoY Change	7.0%
Common Stock	$150.0K		$140.0K
YoY Change	7.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$631.0M	$631.0M	$734.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.045B	$1.045B	$1.074B
YoY Change	-2.68%	-2.68%	9.11%

Cashflow Statement

Concept	2015 Q4	2015	2014 Q4
OPERATING ACTIVITIES
Net Income	$14.98M	$53.14M	$14.80M
YoY Change	1.19%	-0.42%	-10.84%
Depreciation, Depletion And Amortization	$9.700M	$37.11M	$9.300M
YoY Change	4.3%	7.94%	24.0%
Cash From Operating Activities	$20.10M	$83.36M	$17.80M
YoY Change	12.92%	10.12%	47.11%
INVESTING ACTIVITIES
Capital Expenditures	-$19.40M	$58.42M	-$16.60M
YoY Change	16.87%	9.6%	76.6%
Acquisitions
YoY Change
Other Investing Activities	-$5.900M	-$14.37M	-$1.000M
YoY Change	490.0%	4.62%	-64.29%
Cash From Investing Activities	-$25.40M	-$72.78M	-$17.60M
YoY Change	44.32%	26.56%	44.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$10.63M
YoY Change		2350.23%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.80M	-41.68M	-7.300M
YoY Change	267.12%	38.34%	8.96%
NET CHANGE
Cash From Operating Activities	20.10M	83.36M	17.80M
Cash From Investing Activities	-25.40M	-72.78M	-17.60M
Cash From Financing Activities	-26.80M	-41.68M	-7.300M
Net Change In Cash	-32.10M	-31.10M	-7.100M
YoY Change	352.11%	160.55%	4.41%
FREE CASH FLOW
Cash From Operating Activities	$20.10M	$83.36M	$17.80M
Capital Expenditures	-$19.40M	$58.42M	-$16.60M
Free Cash Flow	$39.50M	$24.94M	$34.40M
YoY Change	14.83%	11.35%	60.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015	dei	Trading Symbol TradingSymbol	nhc
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001047335
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15005616
CY2015	dei	Entity Registrant Name EntityRegistrantName	NATIONAL HEALTHCARE CORP
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Type DocumentType	10-K
CY2015Q2	dei	Entity Public Float EntityPublicFloat	505000000
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	nhc	Annual Excess Coverage AnnualExcessCoverage	7500000
	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
	nhc	Annual Excess Coverage AnnualExcessCoverage	4000000
	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
CY2014	nhc	Proceeds Payments Tax Benefit Expense From Stockbased Compensation ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation	201000
CY2013	nhc	Proceeds Payments Tax Benefit Expense From Stockbased Compensation ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation	-225000
CY2015	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	-6277000
CY2015Q4	nhc	Cost To Complete Construction In Progress CostToCompleteConstructionInProgress	29850000
CY2015Q4	nhc	Deferred Tax Assets Accrued Expenses Noncurrent DeferredTaxAssetsAccruedExpensesNoncurrent	3560000
CY2014Q4	nhc	Deferred Tax Assets Accrued Expenses Noncurrent DeferredTaxAssetsAccruedExpensesNoncurrent	2910000
CY2015Q4	nhc	Deferred Tax Assets Accrued Risk Reserves Noncurrent DeferredTaxAssetsAccruedRiskReservesNoncurrent	1806000
CY2014Q4	nhc	Deferred Tax Assets Accrued Risk Reserves Noncurrent DeferredTaxAssetsAccruedRiskReservesNoncurrent	2295000
CY2015Q4	nhc	Deferred Tax Liabilities Unrealized Gains On Marketable Securities DeferredTaxLiabilitiesUnrealizedGainsOnMarketableSecurities	33502000
CY2014Q4	nhc	Deferred Tax Liabilities Unrealized Gains On Marketable Securities DeferredTaxLiabilitiesUnrealizedGainsOnMarketableSecurities	39958000
CY2015	nhc	Direct Business Coverage Statutory Limits DirectBusinessCoverageStatutoryLimits	1000000
CY2007Q3	nhc	Dividend Distribution Rights DividendDistributionRights	1
CY2015	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	6809000
CY2014	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	5957000
CY2013	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	5216000
CY2015	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	40875000
CY2014	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	40908000
CY2013	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	40112000
CY2015	nhc	Gain On The Recovery Of Notes Receivable GainOnTheRecoveryOfNotesReceivable
CY2014	nhc	Gain On The Recovery Of Notes Receivable GainOnTheRecoveryOfNotesReceivable
CY2013	nhc	Gain On The Recovery Of Notes Receivable GainOnTheRecoveryOfNotesReceivable	5454000
CY2015Q4	nhc	Homecare Services Anticipated Payment Deferred Revenue Percentage HomecareServicesAnticipatedPaymentDeferredRevenuePercentage	0.6
CY2015	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	-487000
CY2014	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	238000
CY2013	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	1898000
CY2014	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	1312000
CY2013	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	2352000
CY2010Q4	nhc	Number Of Additional Lease Options NumberOfAdditionalLeaseOptions	5
CY2015Q4	nhc	Number Of Nursing Facilities Under Medicaid Cost Report Audits NumberOfNursingFacilitiesUnderMedicaidCostReportAudits	11
CY2010Q4	nhc	Number Of Patient Beds In Facility NumberOfPatientBedsInFacility	120
CY2015Q4	nhc	Number Of Variable Interest Entities NumberOfVariableInterestEntities	1
CY2015	nhc	Proceeds Payments Tax Benefit Expense From Stockbased Compensation ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation	1942000
CY2015Q2	nhc	Stock Repurchase Program Number Of Plans StockRepurchaseProgramNumberOfPlans	2
CY2015Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	16654000
CY2014Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	22931000
CY2015Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	3440000
CY2014Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	3927000
CY2015Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	20128000
CY2014Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	15877000
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	84095000
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78843000
CY2015Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	65338000
CY2014Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	59859000
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	339241000
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	307048000
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	53364000
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	64608000
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	209469000
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	154965000
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	1942000
CY2014	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	201000
CY2013	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-225000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1982000
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2021000
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2298000
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5583000
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5738000
CY2015Q4	us-gaap	Assets Assets	1045329000
CY2014Q4	us-gaap	Assets Assets	1074123000
CY2015Q4	us-gaap	Assets Current AssetsCurrent	278942000
CY2014Q4	us-gaap	Assets Current AssetsCurrent	322525000
CY2015Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	335348000
CY2014Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	371226000
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	171174000
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	157642000
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	286034000
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	290808000
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	86921000
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	103814000
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2237000
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	824000
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	201350000
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	187818000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	71442000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	58863000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	70223000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	58872000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	74747000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	83542000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	74671000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	84028000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	1694000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	4076000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	1699000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	4183000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	23291000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	11161000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	23273000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	11190000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	169866000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	158273000
CY2015Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	507627000
CY2014Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	487021000
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3279000
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3088000
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	30228000
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	33508000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	42466000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5200000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5200000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5200000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5200000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5200000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	16466000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	8959000
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	33507000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69767000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81705000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66701000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38208000
CY2015Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	38208000
CY2014Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	69767000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-31559000
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-11938000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	15004000
CY2015	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.54
CY2014	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.34
CY2013	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.26
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15000616
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14110859
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15000616
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14110859
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	150000
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	140000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	41899000
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	71792000
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	59990000
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Concentration of Credit Risks</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our credit risks primarily relate to cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, marketable securities, restricted marketable securities and notes receivable. Cash and cash equivalents are primarily held in bank accounts and overnight investments. Restricted cash and cash equivalents is primarily invested in commercial paper and certificates of deposit with financial institutions and other interest bearing accounts. Accounts receivable consist primarily of amounts due from patients (funded through Medicare, Medicaid, other contractual programs and through private payors) and from other health care companies for management, accounting and other services. We perform continual credit evaluations of our clients and maintain allowances for doubtful accounts on these accounts receivable. Marketable securities and restricted marketable securities are held primarily in accounts with brokerage institutions. Notes receivable relate primarily to secured loans with health care facilities (recorded as notes receivable in the consolidated balance sheets) as discussed in Note 10. </div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At any point in time we have funds in our operating accounts and restricted cash accounts that are with third party financial institutions. These balances in the U.S. may exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits. While we monitor the cash balances in our operating accounts, these cash and restricted cash balances could be impacted if the underlying financial institutions fail or could be subject to other adverse conditions in the financial markets. </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our financial instruments, principally our notes receivable, are subject to the possibility of loss of the carrying values as a result of the failure of other parties to perform according to their contractual obligations. We obtain various collateral and other protective rights, and continually monitor these rights in order to reduce such possibilities of loss. We evaluate the need to provide reserves for potential losses on our financial instruments based on management's periodic review of the portfolio on an instrument by instrument basis. See Note 10 for additional information on the notes receivable.</div></div></div></div>
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	54027000
CY2014Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	35687000
CY2015Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	3440000
CY2014Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	3927000
CY2015	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	616757
CY2015	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax
CY2014	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax
CY2013	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	8671000
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	839496000
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	803672000
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	716876000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	29322000
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	30235000
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	34680000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	32890000
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	33330000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40268000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3568000
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3095000
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5588000
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-532000
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1172000
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2226000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-759000
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1506000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2705000
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3315000
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3359000
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-227000
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-334000
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-479000
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4258000
CY2014Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	6197000
CY2015Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	945000
CY2014Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	409000
CY2015Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	7757000
CY2014Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	6737000
CY2015Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	2962000
CY2014Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	2445000
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	28089000
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	35505000
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	18993000
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	18700000
CY2015Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	18700000
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1342000
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1532000
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3135000
CY2014Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3135000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3511000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2879000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	9142000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	7191000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	4860000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3635000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2055000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2138000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	842000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	964000
CY2015Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	423000
CY2014Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	183000
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9096000
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	16805000
CY2015Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	35506000
CY2015Q4	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	35846000
CY2014Q4	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	42242000
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	9096000
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2344000
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2284000
CY2015Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8451000
CY2014Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8791000
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37114000
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34384000
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	28547000
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.99
CY2014	us-gaap	Dividends Common Stock DividendsCommonStock	18974000
CY2015	us-gaap	Dividends Common Stock DividendsCommonStock	22252000
CY2015Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	5996000
CY2014Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7000000
CY2015Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2167000
CY2015Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2152000
CY2015Q4	us-gaap	Dividends Preferred Stock DividendsPreferredStock	332000
CY2014Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2168000
CY2014Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2167000
CY2014Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2167000
CY2014Q4	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2168000
CY2015Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2168000
CY2015	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6819000
CY2014	us-gaap	Dividends Preferred Stock DividendsPreferredStock	8670000
CY2013	us-gaap	Dividends Preferred Stock DividendsPreferredStock	8671000
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37114000
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34384000
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28547000
CY2013	us-gaap	Dividends Common Stock DividendsCommonStock	17719000
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.34
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.24
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.05
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	5263000
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	697000
CY2013	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	196000
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.14
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.87
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	272000
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P73D
CY2015	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	6505000
CY2014	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	10288000
CY2013	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	15473000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	23213000
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	20922000
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	25212000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	26334000
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.20
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	25157000
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	28018000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	7970000
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	7305000
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	8879000
CY2015	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	9589000
CY2014	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	10533000
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	18806000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	11091000
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	11540000
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	11685000
CY2015	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	50464000
CY2014	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	51441000
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	58918000
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	150357000
CY2014Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	142110000
CY2015	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	566000
CY2014	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	379000
CY2013	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	39000
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34700000
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36200000
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40900000
CY2015Q4	us-gaap	Goodwill Goodwill	17600000
CY2014Q4	us-gaap	Goodwill Goodwill	17600000
CY2015	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	41776000
CY2014	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	42396000
CY2013	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	53120000
CY2015	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	864846000
CY2014	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	829287000
CY2013	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	735837000
CY2015Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	222407000
CY2015Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	224902000
CY2015Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	225386000
CY2015Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	233927000
CY2014Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	210531000
CY2014Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	216555000
CY2014Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	218223000
CY2014Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	226374000
CY2015	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	906622000
CY2014	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	871683000
CY2013	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	788957000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	85274000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	85193000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	102176000
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5845000
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6675000
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	14188000
CY2015	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	740000
CY2014	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	319000
CY2013	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	178000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32131000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31824000
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37563000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	29846000
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	29818000
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	35762000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	351000
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	363000
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	197000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	6000
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	27000
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	35000
CY2015	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-372000
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	439000
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-258000
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1767000
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2207000
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2325000
CY2015	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	2674000
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	512000
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	1107000
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	29183000
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	36642000
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	34273000
CY2015Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3203000
CY2014Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4727000
CY2015	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	4251000
CY2014	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2827000
CY2013	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2495000
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11835000
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5215000
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13778000
CY2015	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	5479000
CY2014	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-3603000
CY2013	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	26219000
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	39000
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-110000
CY2015	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	406000
CY2014	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-448000
CY2013	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-1010000
CY2015	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	2285000
CY2014	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	2006000
CY2013	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	1801000
CY2015	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1524000
CY2014	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	4727000
CY2013	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-5933000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	441000
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19000
CY2015	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-354000
CY2014	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-501000
CY2013	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	40000
CY2015	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	648000
CY2014	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1434000
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2404000
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-44000
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	486000
CY2015	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	4500000
CY2014	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	4500000
CY2015	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-6800000
CY2015	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-7455000
CY2014	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-5652000
CY2013	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-6401000
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	283000
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1486000
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	635000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-89000
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2587000
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	76000
CY2015	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-8937000
CY2014	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-9523000
CY2013	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-8039000
CY2015	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	9392000
CY2014	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	6245000
CY2013	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	10405000
CY2015	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	456323
CY2014	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	328669
CY2013	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	232118
CY2015	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock
CY2014	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock
CY2013	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	2623228
CY2015	us-gaap	Interest Expense InterestExpense	2608000
CY2014	us-gaap	Interest Expense InterestExpense	2165000
CY2013	us-gaap	Interest Expense InterestExpense	331000
CY2015	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5494000
CY2014	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	4550000
CY2013	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5237000
CY2015	us-gaap	Interest Paid InterestPaid	2965000
CY2014	us-gaap	Interest Paid InterestPaid	2242000
CY2013	us-gaap	Interest Paid InterestPaid	497000
CY2015Q4	us-gaap	Inventory Net InventoryNet	7568000
CY2014Q4	us-gaap	Inventory Net InventoryNet	7127000
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	37683000
CY2014Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	37116000
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	532735000
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	510249000
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	453560000
CY2015Q4	us-gaap	Land Land	59831000
CY2014Q4	us-gaap	Land Land	58672000
CY2015Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	4500000
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	39967000
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	39731000
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	39449000
CY2015Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	103445000
CY2014Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	98302000
CY2010Q4	us-gaap	Lessee Leasing Arrangements Operating Leases Renewal Term LesseeLeasingArrangementsOperatingLeasesRenewalTerm	P5Y
CY2010Q4	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P10Y
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1045329000
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1074123000
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	150656000
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	183558000
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	120000000
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	10000000
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	110000000
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	10000000
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	120000000
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10000000
CY2015Q4	us-gaap	Malpractice Loss Contingency Number Of Claims MalpracticeLossContingencyNumberOfClaims	32
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	116168000
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	132535000
CY2015Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	18276000
CY2014Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	19805000
CY2015Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	151590000
CY2014Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	138468000
CY2014	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-768000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-41675000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30124000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-31044000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63847000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57508000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56300000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	73963000
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	75694000
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	102348000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	13242000
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	12358000
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	12567000
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	14976000
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	13229000
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	12511000
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	12829000
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	14800000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	53143000
CY2014	us-gaap	Net Income Loss NetIncomeLoss	53369000
CY2013	us-gaap	Net Income Loss NetIncomeLoss	64613000
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11074000
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	44699000
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	64613000
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10191000
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10415000
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14644000
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11061000
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10344000
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10662000
CY2014Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12632000
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	46324000
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	44699000
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	55942000
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	46324000
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	39032000
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4222000
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4130000
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4550000
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5246000
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4572000
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4281000
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3937000
CY2014Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4392000
CY2010Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	4500000
CY2015Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	460000
CY2014Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	441000
CY2015Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	12704000
CY2014Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	12548000
CY2015Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	13164000
CY2014Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	12989000
CY2015Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17436000
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	15706000
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	13761000
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	20223000
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	16988000
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	16083000
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	14736000
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	20204000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	67126000
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	68011000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	72081000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	381950000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	34200000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34200000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	34200000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	34200000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	34200000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	210950000
CY2015Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	9865000
CY2014Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	10219000
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	230341000
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	236854000
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11244000
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	18423000
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4623000
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	566000
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	379000
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	39000
CY2015	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-7062000
CY2014	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	11614000
CY2013	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-2627000
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-17740000
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	30416000
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-7211000
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	227072000
CY2014	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	217143000
CY2013	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	194989000
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12192000
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12472000
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16294000
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16011000
CY2015	us-gaap	Other Noncash Income OtherNoncashIncome
CY2014	us-gaap	Other Noncash Income OtherNoncashIncome
CY2013	us-gaap	Other Noncash Income OtherNoncashIncome	5454000
CY2015	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	18148000
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	17182000
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	30095000
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	41776000
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	42396000
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	53120000
CY2014	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2015	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6995000
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4700000
CY2015	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	130538000
CY2014	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock
CY2013	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	601000
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21089000
CY2014	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	18704000
CY2013	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	17469000
CY2015	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8986000
CY2014	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8670000
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	48786000
CY2015	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	110000000
CY2014	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2013	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8671000
CY2015	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	674000
CY2014	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	1975000
CY2013	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	21000000
CY2015	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5676000
CY2014	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	767000
CY2013	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58416000
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53298000
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43438000
CY2015	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	60540000
CY2014	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	62165000
CY2013	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	93155000
CY2015	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders
CY2014	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	768000
CY2013	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6819000
CY2014	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8670000
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8671000
CY2015Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	15.75
CY2014Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	15.75
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10836659
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10836659
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	170494000
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2171000
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2260000
CY2015	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	4948000
CY2014	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	3156000
CY2013	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	11865000
CY2015	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	47574000
CY2013	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	47574000
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	161000
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10634000
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7429000
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	991000
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	81389000
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	368013000
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	343941000
CY2014	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	48786000
CY2013	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	81389000
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	875287000
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	821792000
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	536046000
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	514744000
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6583000
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6228000
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5226000
CY2015	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	566000
CY2014	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	379000
CY2013	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	39000
CY2015	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	3089000
CY2014	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	2436000
CY2013	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11106000
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10651000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8793000
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7020000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2313000
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3631000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.313
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0071
CY2015	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Deferred Revenue </div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deferred revenue includes the deferred gain on the sale of assets to National (as discussed in Note 2) and entrance fees that have been and are currently being received upon reservation and occupancy in the independent living centers we operate. The non-refundable portion (10%) of the entrance fee is included in deferred revenue and is being recognized over the remaining life expectancies of the residents. </div></div></div></div>
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0052
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0025
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.92
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.15
CY2015Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	98508000
CY2014Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	106218000
CY2015Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27069000
CY2014Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	26825000
CY2015Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	71439000
CY2014Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	79393000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	1982000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	2021000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2298000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0273
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0268
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0281
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.165
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.173
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1074552
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	954678
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	52.31
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5447000
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	621390
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	46.69
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	57672
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.75
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.44
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	98000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	20000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	51.11
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	57716
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56210
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8422000
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1134602
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	45.63
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	45.97
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	47.06
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	47.95
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	53.10
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	61.47
CY2015Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y73D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y73D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y36D
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1512000
CY2015Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.90
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	19722
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	157590
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	389498
CY2013	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	991000
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7429000
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10634000
CY2013Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	100000
CY2013Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4700000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	656148000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	688112000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	734148000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	630996000
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4700000
CY2014	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	6995000
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	13162000
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	13620000
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12453000
CY2015Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3132000
CY2014Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2391000
CY2013Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2072000
CY2015	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-2551000
CY2014	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-2059000
CY2013	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-2802000
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2141000
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1542000
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1605000
CY2015Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	5831000
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	4895000
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	4200000
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div>
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14491433
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14222133
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16698803
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13889134
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13816095
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13829626

Files In Submission

Name	View Source	Status
0001047335-16-000180-index-headers.html	Edgar Link	pending
0001047335-16-000180-index.html	Edgar Link	pending
0001047335-16-000180.txt	Edgar Link	pending
0001047335-16-000180-xbrl.zip	Edgar Link	pending
exhibit1016firstamendmentto2.htm	Edgar Link	pending
exhibit21subsidiariesofthere.htm	Edgar Link	pending
exhibit23.htm	Edgar Link	pending
exhibit311adams.htm	Edgar Link	pending
exhibit312daniel.htm	Edgar Link	pending
exhibit32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhc-20151231.xml	Edgar Link	completed
nhc-20151231.xsd	Edgar Link	pending
nhc-20151231_cal.xml	Edgar Link	unprocessable
nhc-20151231_def.xml	Edgar Link	unprocessable
nhc-20151231_lab.xml	Edgar Link	unprocessable
nhc-20151231_pre.xml	Edgar Link	unprocessable
nhc2015form10kfile.htm	Edgar Link	pending
nhc2015form10kfile001.jpg	Edgar Link	pending
nhc2015form10kfile003.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2015 Q4 Form 10-K Financial Statement

#000104733516000180 Filed on February 19, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2015 Q4 Form 10-K Financial Statement

#000104733516000180 Filed on February 19, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc